Federal funding analysis
Reported transaction obligations
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Histories follow awards currently assigned to this recipient and may include transactions under an earlier recipient. Coverage: 6 of 6 selected awards have dated, valued transactions.
Funding change
Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.
| Measure | Reported value |
|---|---|
| Current period | Oct 1, 2025 – Sep 30, 2026 |
| Current obligations | $-1.1M |
| Prior period | Oct 1, 2024 – Sep 30, 2025 |
| Prior obligations | $63.0K |
| Change | $-1.1M |
| Growth | -1783.4%Why this funding changeNet obligations in equal-length adjacent periods. ($-1,060,538.10 − $63,000.00) ÷ $63,000.00 × 100 = -1783.39%
Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Negative obligation adjustments can produce a decline below −100%. |
Where the work is performed
State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.
Agencies
| Category | Period obligations | Awards |
|---|---|---|
| Department of Health and Human Services | $4.0M | 5 |
| Department of Defense | $-1.1M | 1 |
Offices
| Category | Period obligations | Awards |
|---|---|---|
| BARDA - ASPR / DAAPPO / BARDA DCMA | $4.0M | 1 |
| CDC OFFICE OF ACQUISITION SERVICES | $62.1K | 2 |
| ASPR/DAAPPO/ORM HQ | $0 | 1 |
| NIH NCI | $0 | 1 |
| DEFENSE HEALTH AGENCY | $-1.1M | 1 |
Naics
| Category | Period obligations | Awards |
|---|---|---|
| 541711 | $2.8M | 2 |
| 325413 — In-Vitro Diagnostic Substance Manufacturing | $62.1K | 3 |
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | $0 | 1 |
Psc
Vehicles
| Category | Period obligations | Awards |
|---|---|---|
| Unclassified | $4.0M | 5 |
| W81XWH16D0009 | $-1.1M | 1 |
Set Asides
| Category | Period obligations | Awards |
|---|---|---|
| NO SET ASIDE USED. | $4.0M | 4 |
| SMALL BUSINESS SET ASIDE - TOTAL | $0 | 1 |
| Unclassified | $-1.1M | 1 |